BioNTech SE
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,244,800 | $128,700 | $187,600 | $1,479,000 |
Gross Profit | 1,065,900 | 68,900 | 128,500 | 1,299,900 |
EBITDA | 211,100 | -748,600 | -288,800 | 507,400 |
EBIT | 166,700 | -798,500 | -327,325 | 428,600 |
Net Income | 198,100 | -807,800 | -315,100 | 457,900 |
Net Change In Cash | 1,244,800 | 128,700 | 187,600 | 1,479,000 |
Free Cash Flow | -721,900 | 1,500,662 | -454,200 | 660,700 |
Cash | 9,624,600 | 10,376,700 | 8,976,600 | 11,663,700 |
Basic Shares | 244,567 | 240,416 | 240,534 | 241,874 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $3,819,000 | $17,310,600 | $18,976,700 | $482,325 |
Gross Profit | 3,219,200 | 12,778,600 | 15,116,000 | -222,037 |
EBITDA | 1,087,600 | 12,427,100 | 15,002,300 | -105,100 |
EBIT | 904,200 | 12,306,020 | 14,924,100 | -141,197 |
Net Income | 930,300 | 9,434,400 | 10,292,500 | 15,200 |
Net Change In Cash | 3,819,000 | 17,310,600 | 18,976,700 | 482,325 |
Free Cash Flow | 4,665,900 | 13,214,100 | 735,700 | -98,920 |
Cash | 11,663,700 | 13,875,100 | 1,692,700 | 1,210,209 |
Basic Shares | 242,700 | 249,800 | 259,700 | 248,527 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.88 |
2024-06-30 | -$3.36 |
2024-03-31 | -$1.41 |
2023-12-31 | $1.90 |
